Literature DB >> 12795645

Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism.

K Kaczirek1, A Soleiman, M Schindl, C Passler, C Scheuba, G Prager, K Kaserer, B Niederle.   

Abstract

BACKGROUND: Nesidioblastosis in adults has been reintroduced into the differential diagnosis of organic hyperinsulinism by the description of 'noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)'.
MATERIALS AND METHODS: Pathologic specimens of all adult patients (n = 66) operated on for organic hyperinsulinism were re-examined. Five patients fulfilled the histomorphological criteria of nesidioblastosis. Retrospective review of clinical presentation, results of 72-h fasts, intravenous tolbutamide tolerance tests, pre- and intraoperative localization studies and surgical therapy was performed.
RESULTS: In contrast to NIPHS, fasting tests became positive after 8-14 h. Tolbutamide tests were positive and preoperative imaging showed negative results in all patients. At first operation distal pancreatic resections were performed in three patients, resection of the pancreatic body in one patient and biopsy of the pancreatic tail in one patient. Two of three patients with recurrent disease had to be reoperated. One patient showed a coexistence of nesidioblastosis and multiple small insulinomas and is part of a kindred with autosomal dominantly inherited 'familial islet-cell adenomatosis'.
CONCLUSIONS: Surgical exploration is indicated only after thorough biochemical diagnosis. An aggressive strategy for preoperative localization including selective arterial calcium stimulation testing seems justified. There may be a combination of nesidioblastosis and islet cell tumours. A link between beta-cell hyperplasia and progression to insulinoma based on not yet known genetic causes can be suspected.

Entities:  

Mesh:

Year:  2003        PMID: 12795645     DOI: 10.1046/j.1365-2362.2003.01158.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.

Authors:  Scott M Thompson; Adrian Vella; Geoffrey B Thompson; Kandelaria M Rumilla; F John Service; Clive S Grant; James C Andrews
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

2.  Surgical treatment of persistent hyperinsulinemic hypoglycemia (PHH) (insulinoma and nesidioblastosis).

Authors:  Daniel Casanova; Manuel G Polavieja; Angel Naranjo; Fernando Pardo; Fernando Rotellar; Francisco Gonzalez; Cristina Luzuriaga; Sara Regaño; Julio Freijanes
Journal:  Langenbecks Arch Surg       Date:  2007-03-21       Impact factor: 3.445

Review 3.  Current concepts in functioning endocrine tumors of the pancreas.

Authors:  Charles A G Proye; Jonathan S Lokey
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

Review 4.  Nesidioblastosis: an old term and a new understanding.

Authors:  Klaus Kaczirek; Bruno Niederle
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

Review 5.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 6.  Hypoglycaemia following upper gastrointestinal surgery: case report and review of the literature.

Authors:  Brandon Bernard; Gregory A Kline; F John Service
Journal:  BMC Gastroenterol       Date:  2010-07-08       Impact factor: 3.067

7.  Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome.

Authors:  Achim Starke; Christiane Saddig; Barbara Kirch; Cyrus Tschahargane; Peter Goretzki
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

8.  The importance of preoperative localisation procedures in organic hyperinsulinism--experience in 67 patients.

Authors:  Klaus Kaczirek; Ahmed Ba-Ssalamah; Wolfgang Schima; Bruno Niederle
Journal:  Wien Klin Wochenschr       Date:  2004-06-30       Impact factor: 1.704

9.  Generation and characterization of human insulin-releasing cell lines.

Authors:  Leticia Labriola; Maria G Peters; Karin Krogh; Iván Stigliano; Letícia F Terra; Cecilia Buchanan; Marcel C C Machado; Elisa Bal de Kier Joffé; Lydia Puricelli; Mari C Sogayar
Journal:  BMC Cell Biol       Date:  2009-06-19       Impact factor: 4.241

10.  Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge.

Authors:  Angela Dardano; Giuseppe Daniele; Roberto Lupi; Niccolò Napoli; Daniela Campani; Ugo Boggi; Stefano Del Prato; Roberto Miccoli
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-24       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.